Cargando…
Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875858/ https://www.ncbi.nlm.nih.gov/pubmed/35227900 http://dx.doi.org/10.1016/j.anai.2022.02.014 |
| _version_ | 1784658032449290240 |
|---|---|
| author | Bragança, Mariana Plácido, José Luís Amaral, Luís |
| author_facet | Bragança, Mariana Plácido, José Luís Amaral, Luís |
| author_sort | Bragança, Mariana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8875858 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88758582022-02-25 Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments Bragança, Mariana Plácido, José Luís Amaral, Luís Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-05 2022-02-25 /pmc/articles/PMC8875858/ /pubmed/35227900 http://dx.doi.org/10.1016/j.anai.2022.02.014 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters Bragança, Mariana Plácido, José Luís Amaral, Luís Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments |
| title | Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments |
| title_full | Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments |
| title_fullStr | Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments |
| title_full_unstemmed | Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments |
| title_short | Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments |
| title_sort | ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: safety of restarting administrations without dose adjustments |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875858/ https://www.ncbi.nlm.nih.gov/pubmed/35227900 http://dx.doi.org/10.1016/j.anai.2022.02.014 |
| work_keys_str_mv | AT bragancamariana ultrarushimmunotherapywithpolymerizedextractsduringthecoronavirusdisease2019pandemicsafetyofrestartingadministrationswithoutdoseadjustments AT placidojoseluis ultrarushimmunotherapywithpolymerizedextractsduringthecoronavirusdisease2019pandemicsafetyofrestartingadministrationswithoutdoseadjustments AT amaralluis ultrarushimmunotherapywithpolymerizedextractsduringthecoronavirusdisease2019pandemicsafetyofrestartingadministrationswithoutdoseadjustments |